Summary Basis of Decision (SBD) for Istodax
Romidepsin, 10 mg/vial, lyophilized powder for solution, intravenous infusion
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00256
2017
false
false
false
Canada
French
English
romidepsin
romidepsin
romidepsin
drug approval
canada
treatment outcome
infusions, intravenous
Romidepsin 10mg injection solution (product)
antibiotics, antineoplastic
antibiotics, antineoplastic
lymphoma, T-Cell, peripheral
recurrence
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
histone deacetylase inhibitors
histone deacetylase inhibitors
drug information
depsipeptides
depsipeptides
---
